"Hematologic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that act on blood and blood-forming organs and those that affect the hemostatic system.
Descriptor ID |
D006401
|
MeSH Number(s) |
D27.505.954.502
|
Concept/Terms |
Hematologic Agents- Hematologic Agents
- Agents, Hematologic
- Hematological Agents
- Agents, Hematological
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Agents".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Agents".
This graph shows the total number of publications written about "Hematologic Agents" by people in this website by year, and whether "Hematologic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hematologic Agents" by people in Profiles.
-
Fantasia HC, Morse BL. Voxelotor for the Treatment of Sickle Cell Disease. Nurs Womens Health. 2020 Jun; 24(3):233-237.
-
Baker JF, Leonard CE, Lo Re V, Weisman MH, George MD, Kay J. Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives. Arthritis Rheumatol. 2020 07; 72(7):1067-1071.
-
Michelson AD, Smolensky Koganov E, Forde EE, Carmichael SL, Frelinger AL. Avatrombopag increases platelet count but not platelet activation in patients with thrombocytopenia resulting from liver disease. J Thromb Haemost. 2018 12; 16(12):2515-2519.
-
Mathew S, Adel N, Rice RD, Panageas K, Duck ET, Comenzo RL, Kewalramani T, Nimer SD. Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients. Bone Marrow Transplant. 2010 Oct; 45(10):1522-7.
-
Kereiakes DJ, Tcheng J, Fry ET, Bhatt DL, Bosker G, Diez JG, Ferguson JJ, Levine GN, Schaer GL, Zidar J. Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for optimizing patient outcomes in NSTE-ACS. J Invasive Cardiol. 2003 Sep; 15(9):536-53.